Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jul 28;292(30):12383-12389.
doi: 10.1074/jbc.R116.767723. Epub 2017 Jun 14.

Control of immune-mediated pathology via the aryl hydrocarbon receptor

Affiliations
Review

Control of immune-mediated pathology via the aryl hydrocarbon receptor

Michael A Wheeler et al. J Biol Chem. .

Abstract

Genetic and environmental factors contribute to the development of immune-mediated diseases. Although numerous genetic factors contributing to autoimmunity have been identified in recent years, our knowledge on environmental factors contributing to the pathogenesis of autoimmune diseases and the mechanisms involved is still limited. In this context, the diet, microbiome, geographical location, as well as environmental pollutants have been shown to modulate autoimmune disease development. These environmental factors interact with cellular components of the immune system in distinct and defined ways and can influence immune responses at the transcriptional and protein level. Moreover, endogenous metabolites generated from basic cellular processes such as glycolysis and oxidative phosphorylation also contribute to the shaping of the immune response. In this minireview, we highlight recent progress in our understanding of the modulation of the immune response by the aryl hydrocarbon receptor (AhR), a ligand-activated transcription factor whose activity is regulated by small molecules provided by diet, commensal flora, environmental pollutants, and metabolism. We focus on the role of AhR in integrating signals from the diet and the intestinal flora to modulate ongoing inflammation in the central nervous system, and we also discuss the potential therapeutic value of AhR agonists for multiple sclerosis and other autoimmune diseases.

Keywords: aryl hydrocarbon receptor (AhR); astrocyte; immunology; lymphocyte; neuroimmunology.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest with the contents of this article

Figures

Figure 1.
Figure 1.
AhR transcriptional mechanisms that regulate the function of T-cell subsets. A, IL-27 induces c-Maf and AhR expression through a STAT3-dependent mechanism in Tr1 cells. AhR and c-Maf cooperate to promote the expression of IL-10 and IL-21. B, metabolic control of Tr1 cell differentiation by ATP and tryptophan metabolites working through HIF1-α and AhR, respectively. AhR promotes CD39 (ENTPD1) expression, which depletes extracellular ATP by catalyzing the conversion of AMP to adenosine. Extracellular ATP suppresses Tr1 cell differentiation by promoting AhR degradation through a mechanism mediated by P2RX7 and HIF1-α. C, AhR and STAT3 cooperate to induce Aiolos expression, which controls the epigenetic status of Il2 and limits its expression during Th17 cell differentiation.
Figure 2.
Figure 2.
Control of astrocyte-driven pathogenesis by AhR signaling. AhR activation by agonists provided by the diet, gut flora, and metabolism limits NF-κB signaling and consequently astrocyte-driven pathogenesis.

References

    1. Dendrou C. A., Fugger L., and Friese M. A. (2015) Immunopathology of multiple sclerosis. Nat. Rev. Immunol. 15, 545–558 - PubMed
    1. Rothhammer V., Mascanfroni I. D., Bunse L., Takenaka M. C., Kenison J. E., Mayo L., Chao C. C., Patel B., Yan R., Blain M., Alvarez J. I., Kébir H., Anandasabapathy N., Izquierdo G., Jung S., et al. (2016) Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor. Nat. Med. 22, 586–597 - PMC - PubMed
    1. Glass C. K., Saijo K., Winner B., Marchetto M. C., and Gage F. H. (2010) Mechanisms underlying inflammation in neurodegeneration. Cell 140, 918–934 - PMC - PubMed
    1. Trapp B. D., and Nave K.-A. (2008) Multiple sclerosis: an immune or neurodegenerative disorder? Annu. Rev. Neurosci. 31, 247–269 - PubMed
    1. Quintana F. J., Jin H., Burns E. J., Nadeau M., Yeste A., Kumar D., Rangachari M., Zhu C., Xiao S., Seavitt J., Georgopoulos K., and Kuchroo V. K. (2012) Aiolos promotes TH17 differentiation by directly silencing Il2 expression. Nat. Immunol. 13, 770–777 - PMC - PubMed

Publication types

Substances

LinkOut - more resources